Crowdonomics
All companies

Innovative Health Solutions, Inc.

Operating

Healthcare · Versailles, IN

Estimated pre-money ⓘ
$14.4M
As of Jul 2021 · from Reg A Offering (2021) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$10,542,000
Crowd $0 · Private $10.5M · 3 rounds since 2017
Latest share price
$10.00
Reg A Offering (2021) offering price

Financials

FY2020 · from SEC filings · hover any figure for its source
$2.2M
−$3.4M
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 audited
Income statement
Revenue
$2,190,764
Cost of goods sold
$954,420
Gross margin
56%
Net income
-$3,424,435
Balance sheet
Cash
$1,895,475
Accounts receivable
$435,525
Total assets
$2,868,129
Long-term debt
$151,005
Total liabilities
$893,614
Other
Headcount
18

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$14.4M
est. pre-money
Reg A+ · Equity · Jul 2021

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Sep 14, 2021
Series A Preferred Stock · 30.8%Series Seed Preferred Stock · 7.41%Common Stock · 61.8%
ClassOutstandingVotes / shareShare of totalLiquidationDividendLast price
Series A Preferred Stockpreferred479,610—30.8%1× · paid 1st8% cumulative—
Series Seed Preferred Stockpreferred(as of Jul 19, 2021)115,47717.41%1× · paid 2nd——
Common Stock964,002161.8%paid 3rd——
Total1,559,089100%

Shares outstanding over timein today's share terms

2.0M1.0M0
Jul 2021Sep 2021
Common StockSeries A Preferred StockSplit / conversion

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Sep 14, 2021

  • Dr. Chris Brown2,014,232 Common Stock45.0%of votes
  • Gary Peterson1,286,240 Common Stock28.7%of votes
  • Dan Clarence272,044 Common Stock6.07%of votes
  • Brian Carrico54,236 Common Stock1.21%of votes
  • Tom Carrico20,000 Common Stock0.45%of votes
  • Everyone else (not named in filings)18.6%

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $20MEst. pre-money $14.4M
Raised $9.6MInvestors 18
Raised $975KInvestors 3

Team

6 people
Dr. Chris BrownFounder
Director (Founder)
Gary PetersonFounder
Chairman (Founder)
Brian Carrico
Chief Executive Officer
Dan Clarence
Chief Operating Officer
Dr. Adrian Miranda [1]
Chief Medical Officer
Tom Carrico
Chief Regulatory Officer

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

SEC filings

  • Form QUALIFSep 20, 20219999999994-21-000296
    EDGAR
  • Form 1-A/ASep 14, 20210001096906-21-002249
    EDGAR
  • Form 1-A/ASep 10, 20210001096906-21-002239
    EDGAR
  • Form 1-AJul 21, 20210001096906-21-001659
    EDGAR
  • Form D/AApr 14, 20200001720973-20-000001
    EDGAR
  • Form DNov 15, 20190001720973-19-000001
    EDGAR
  • Form DOct 30, 20170001720973-17-000001
    EDGAR
Source: SEC EDGARCIK 0001720973INShare price $10.00Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.